
|Videos|June 11, 2019
Dr. Ramalingam on Pemetrexed and Bevacizumab as Maintenance Therapy for Advanced NSCLC
Author(s)Suresh S. Ramalingam, MD
Cancer Network spoke with Suresh S. Ramalingam, MD, of Emory University, about pemetrexed, bevacizumab, or both for advanced non-squamous NSCLC.
Advertisement
Cancer Network spoke with Suresh S. Ramalingam, MD, professor of hematology/oncology and the deputy director of Winship Cancer Institute, Emory University, about the results of the ECOG-ACRIN 5508 trial (
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Ultra-Hypofractionation Proves Feasible in Locally Advanced Breast Cancer
2
GLP-1 Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways
3
Mezigdomide Regimen Boosts PFS in Relapsed/Refractory Multiple Myeloma
4
Dato-DXd/Durvalumab Shows Promising Outcomes in Advanced TNBC
5























































